Special treat Longjin (002750.SZ): Received the pharmaceutical registration certificate for sildenafil citrate orally disintegrating tablets.

*ST Longjin (002750.SZ) announced that the company's controlling subsidiary yunnan Longjin Kangyou Biomedical Co., Ltd.

Zhitong FinanceNov 11 22:42 ET

*ST Longjin: 2024 Third Quarter Report

SZSIOct 30 12:00 ET · Announcements

*ST Longjin: 2024 Semi-Annual Report Summary

SZSIAug 27 12:00 ET · Announcements

*ST Longjin: 2024 Semi-Annual Report

SZSIAug 27 12:00 ET · Announcements

ST Longjin (002750.SZ): Net loss of 4.224 million yuan in the first half of the year.

Geelong reported its semi-annual report for 2024 on August 27th. The report shows a revenue of 39.4178 million yuan for the reporting period, a decrease of 9.66% year-on-year. The net income attributable to the company's shareholders is -4.224 million yuan, with a narrowed loss year-on-year. The net income attributable to the company's shareholders after deducting non-recurring gains and losses is -11.4206 million yuan. The basic earnings per share is -0.0105 yuan.

Gelonghui FinanceAug 27 05:18 ET

ST Longjin (002750.SZ) released its performance for the first half of the year, with a net loss of 4.224 million yuan.

*ST Longjin (002750.SZ) released its 2024 semi-annual report, during the reporting period, the company achieved operating income...

Zhitong FinanceAug 27 04:33 ET